Lates News

Vertex Pharmaceuticals' adjusted EPS for the first quarter was $4.06, analysts had expected $4.29. The company's total revenue for the year is estimated to be between $1.85 billion and $1.2 billion, compared to the original forecast of $1.8 billion to $1.2 billion. Vertex Pharmaceuticals' (VRTX) stock fell 2.84% after hours.